News Pharma attacks plan to ration new drugs in England Plans to ration and delay use of novel drugs in England have been condemned by the pharma industry and a health charity.
News Novo Nordisk looking at M&A to revive fortunes, says CEO Novo Nordisk’s new CEO Lars Fruergaard Joergensen says it is considering M&A to shore up performance as its key US diabetes sales come under pressure.
Views & Analysis The Berlin Declaration – driving early action in type 2 diab... International initiative helps countries focus on best policies for overcoming diabetes.
Views & Analysis Disruptive innovation, integrated care the only way forward,... Peter Guenter, head of Sanofi’s Diabetes & Cardiovascular business, on the future of chronic disease care.
News Pfizer and Merck's diabetes contender looks to challenge Jar... Merck and Pfizer have Boehringer and Lilly in their sights with ertugliflozin
Views & Analysis Digital Health Round-up: Can digital resolve NHS' data secur... A round-up of this week's digital healthcare news. Marco Ricci reports.
Patients Delivering the right behavioural ingredients for the moment,... Lirio's Dr Amy Bucher discusses the risks of the declining trust in healthcare institutions from a behavioural science perspective.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
